Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
about
Human Cellular Retinaldehyde-Binding Protein Has Secondary Thermal 9- cis -Retinal Isomerase ActivityReduced retinal microvascular density, improved forepaw reach, comparative microarray and gene set enrichment analysis with c-jun targeting DNA enzymeQLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles.Key enzymes of the retinoid (visual) cycle in vertebrate retinaDietary 9-cis-β,β-carotene fails to rescue vision in mouse models of leber congenital amaurosisImprovement in vision: a new goal for treatment of hereditary retinal degenerationsM-opsin protein degradation is inhibited by MG-132 in Rpe65⁻/⁻ retinal explant cultureA microparticle/hydrogel combination drug-delivery system for sustained release of retinoids.S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCAVitamin A derivatives as treatment options for retinal degenerative diseases.Light damage in Abca4 and Rpe65rd12 mice.Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.Lecithin:Retinol Acyltransferase: A Key Enzyme Involved in the Retinoid (visual) Cycle.iPSC-Derived Retina Transplants Improve Vision in rd1 End-Stage Retinal-Degeneration MiceFlavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa.Complex binding pathways determine the regeneration of mammalian green cone opsin with a locked retinal analogue.Light prevents exogenous 11-cis retinal from maintaining cone photoreceptors in chromophore-deficient mice.
P2860
Q27680865-00D2F428-8E3F-4A9A-B16D-CF8ABC1EE31EQ34344676-6DEEB8C8-00BC-414A-A0E8-94DC1EF634CDQ34515268-033226E7-7B96-4769-9D35-9F6E7045E7E0Q35172750-D16DA562-A74E-4A32-BD74-0873BC9BE35FQ35415871-E5929480-4D56-45A4-BE63-652C8507B132Q35805426-4479EF37-546A-421A-A73B-138B157CC7A5Q36051615-3300EE40-F401-40A5-B174-D2F2E8B3CF36Q36299877-A1CB1E8F-8945-4CEB-BF94-AD6049EA9366Q36709143-8AF1758C-5C7C-4A2B-A793-069BA3332808Q37083819-91007835-5BB8-4711-8EBB-DD16C300A024Q37680148-A6418BA5-A1A2-4F73-8588-0F7D6590484AQ37836902-B240E9E1-E168-4D87-BCE1-3296BED03679Q38835275-E4C0AAB7-5F52-4378-BFD5-01DEFD56B5A4Q39026785-2D98E778-ACF6-481F-9466-0AC454B4B22FQ41330115-5456F540-27E7-4648-82CA-66667B79300DQ41986906-4F30FD7B-E3D7-407E-B611-5799ED46FEF2Q42721004-365510D0-D291-4E98-8E19-1C207EE5B78E
P2860
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@ast
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@en
type
label
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@ast
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@en
prefLabel
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@ast
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@en
P2093
P2860
P356
P1476
Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice
@en
P2093
Akiko Maeda
Gemma Casadesus
Philippe Margaron
Tadao Maeda
P2860
P304
P356
10.1167/IOVS.09-3700
P407
P577
2009-04-30T00:00:00Z